These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16603404)

  • 1. [RCP: prevention in materno-fetal Rh immunization (CNGOF, December 2005). We don't have to forget to control the efficacy of these guidelines, as well as the prescription of the innovating technique in this field].
    Sagot P
    Gynecol Obstet Fertil; 2006 Apr; 34(4):358-9. PubMed ID: 16603404
    [No Abstract]   [Full Text] [Related]  

  • 2. [Should the RhD prophylaxis be adjusted?].
    Georgsen J; Sprogøe U
    Ugeskr Laeger; 2004 Aug; 166(36):3072. PubMed ID: 15446237
    [No Abstract]   [Full Text] [Related]  

  • 3. [Recommendations for clinical practice. Prevention in maternofetal Rh immunization (December 2005)].
    Collège National des Gynécologues et Obstétriciens Français
    Gynecol Obstet Fertil; 2006 Apr; 34(4):360-5. PubMed ID: 16644259
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention of Rh immunization. II. Management of the risk during the second half of pregnancy and postpartum].
    Larsen JF; Bock JE; Jørgensen JR
    Ugeskr Laeger; 2004 Aug; 166(36):3078-83. PubMed ID: 15387304
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prevention of Rh immunization. I. Theoretical background and management of the risk during the first half of pregnancy].
    Larsen JF; Bock JE; Jørgensen JR
    Ugeskr Laeger; 2004 Aug; 166(36):3073-8. PubMed ID: 15387303
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical guidelines on anti-D prophylaxis: hasty critics?].
    Carbonne B; Marpeau L; Brossard Y
    J Gynecol Obstet Biol Reprod (Paris); 2007 Oct; 36(6):526-8. PubMed ID: 17893030
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prenatal immunoglobulin prevention in Rh(D)-negative nonsensitized pregnant women].
    Katsulov A
    Akush Ginekol (Sofiia); 1997; 36(2):1-2. PubMed ID: 9471891
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prophylactic anti-D for RhD- patient in France: an hasty recommendation?].
    Benachi A; Nisand I
    J Gynecol Obstet Biol Reprod (Paris); 2007 Oct; 36(6):523-5. PubMed ID: 17651919
    [No Abstract]   [Full Text] [Related]  

  • 9. [RhD immunoprophylaxis should be adjusted].
    Bock JE; Larsen JF
    Ugeskr Laeger; 2004 Aug; 166(36):3113. PubMed ID: 15387315
    [No Abstract]   [Full Text] [Related]  

  • 10. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM
    Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
    [No Abstract]   [Full Text] [Related]  

  • 11. Rho (D) immune globulin i.v. for prevention of Rh isoimmunization and for treatment of ITP.
    Med Lett Drugs Ther; 1996 Jan; 38(966):6-8. PubMed ID: 8544794
    [No Abstract]   [Full Text] [Related]  

  • 12. Preventing RhD haemolytic disease of the newborn. Guidelines are not followed in many cases.
    McFadyen IR; Martlew VJ; Howard HL; Clarke CA
    BMJ; 1998 Apr; 316(7138):1165. PubMed ID: 9569417
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-D guidelines.
    Kanjilal K; Tasker M
    Br J Fam Plann; 2000 Oct; 26(4):244. PubMed ID: 11053891
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevention of hemolytic disease of the fetus and the newborn: it is necessary to act].
    Mannessier L; Alie-Daram S; Roubinet F; Valat AS; Depoortère MH; Fournié A; Puech F
    J Gynecol Obstet Biol Reprod (Paris); 2000 Sep; 29(5):441-4. PubMed ID: 11011272
    [No Abstract]   [Full Text] [Related]  

  • 15. "The use of Rh-immune globulin".
    Lavery JP
    Nebr Med J; 1987 May; 72(5):175-6. PubMed ID: 3035388
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevention with anti-D gamma globulin at the Research Institute of Obstetrics and Gynecology].
    Spasova K; Vŭlcheva B
    Akush Ginekol (Sofiia); 1984; 23(6):500-4. PubMed ID: 6099699
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-D administration in early pregnancy--time for a new protocol.
    Carmody F
    Aust N Z J Obstet Gynaecol; 1996 May; 36(2):227-8. PubMed ID: 8798328
    [No Abstract]   [Full Text] [Related]  

  • 18. Compliance with routine antenatal rhesus D prophylaxis and the impact on sensitisations: observations over 14 years.
    MacKenzie IZ; Findlay J; Thompson K; Roseman F
    BJOG; 2006 Jul; 113(7):839-43. PubMed ID: 16827770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of monoclonal anti-D immunoglobulin in comparison with polyclonal anti-D immunoglobulin in prevention of rho isoimmunization.
    Chauhan AR; Bhattacharyya MS; Turakhia N; Daftary GV
    J Assoc Physicians India; 2002 Oct; 50():1341-2. PubMed ID: 12568238
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevention of neonatal alloimmune thrombocytopenia fetal maternal rhesus].
    Poissonnier MH
    J Gynecol Obstet Biol Reprod (Paris); 2007 Sep; 36 Suppl 1():S12-5. PubMed ID: 18228707
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.